ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2910

Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life

Kathleen Morrisroe1, Molla Huq2, Wendy Stevens3, Joanne Sahhar4, Susanna Proudman5,6, Mandana Nikpour7 and Australian Scleroderma Interest Group, 1Rheumatology, St Vincent's Hospital, Melbourne, Melbourne, Australia, 2Department of Medicine (Rheumatology), Melbourne University, Melbourne, Australia, 3Department of Rheumatology, St. Vincent’s Hospital Melbourne, Melbourne, Australia, 4Department of Rheumatology, Monash Medical Centre, Melbourne, Australia, 5Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, 6Discipline of Medicine, University of Adelaide, Adelaide, Australia, 7Melbourne University, Melbourne, Australia

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We sought to assess work productivity, factors associated with reduced productivity, and the relationship between work productivity and health-related quality of life (HRQoL) in systemic sclerosis (SSc).

Methods: This is a cross-sectional study of SSc patients identified through the Australian Scleroderma Cohort Study database. All patients were mailed 2 employment questionnaires (Workers Productivity and Activity Impairment Questionnaire (WPAI) and a self-made questionnaire) and 2 HRQoL questionnaires (SF-36 and PROMIS 29). Summary statistics, chi-square tests and linear regression were used to determine the associations of work productivity.

Results: Of 800 questionnaires, 476 were returned, equating to a response rate of 59.5%. Of those aged under 65 years (standard retirement age in Australia), 55.2% were employed. Unemployed patients were older at the time of survey completion (57.1 vs 53.7, p<0.001) and had longer disease duration from the first clinical manifestation of SSc (16.2 vs 14.9, p=0.01) than those who were employed. The mean age of unemployment was ten years less than the average Australian retirement age. Disease characteristics by employment status are outlined in Table 1. Of those in paid employment, 16.0% reported missing work (absenteeism) in the past week due to SSc, accounting for 32.9% of their working time. The mean number of missed work due to SSc was 11.4 (±10.9) hours. For all employed patients, the overall mean number of hours worked in the last week was 26.9 (±13.3), well below the average Australian full-time working week (38-hours). Only 27% of patients were working ≥38 hours a week. Of those working, 22% of their working time was impaired due to SSc (‘presenteeism’). The mean overall work impairment accounted for 24.4% of working time.  Additionally, 37.9% of the patients’ daily activities had been prevented due to their SSc. Factors associated with overall work impairment (absenteeism and presenteeism) included a lack of tertiary education (p=0.04), synovitis (p=0.05) and sicca symptoms (p=0.03). Factors associated with impairments in daily activities included a lack of tertiary education (p=0.04), interstitial lung disease (p=0.01), digital amputation (p=0.005) and sicca symptoms (p=0.001). Unemployed patients had significantly lower HRQoL scores across a number of SF-36 domains compared with employed patients, which was mirrored in the PROMIS-29 (Table 2).  

Conclusion: SSc is associated with substantial unemployment and reduced productivity, which is in turn associated with poor HRQoL. Raising awareness and identifying modifiable risk factors are possible ways of reducing this burden.  

Table 1 Patient characteristics according to employment status

in those less than 65 years of age

Variables

Employed

mean±SD or n(%)

Unemployed

mean±SD or n(%)

p-value

Total number of patients

133 (55.2%)

108 (44.8%)

<0.001

Female

116 (87.2%)

98 (90.7%)

0.93

Age at completion of survey years

53.7±7.9

57.1±6.6

0.001

Disease duration at survey, years

14.9±8.3

16.2±9.7

0.31

Age at unemployment, years

n/a

48.3 (9.1)

 

Race    Caucasian    Asian    Aboriginal-Islander    Hispanic    Other

117 (90.7%)

5 (3.9%)

3 (2.3%)

1 (0.8%)

3 (2.3%)

93 (90.3%)

8 (7.8%)

2 (1.9%)

0 (0%)

0 (0%)

0.31

Tertiary education

82 (63%)

55 (52.9%)

0.12

Physical nature of job (current or past)

39 (32.5%)

44 (44.9%)

0.06

SSc subtype     lcSSc     dcSSc     MCTD

98 (73.7%)

34 (25.6%)

0 (0%)

74 (68.5%)

32 (29.6%)

2 (1.9%)

0.01

Clinical manifestations#    Gastrointestinal involvement    Synovitis    Small joint contractures in hands    Digital ulcers    Digital amputation    Calcinosis    Sicca symptoms    PAH    ILD    Renal Crisis    Myositis    Tendon friction rubs    Modified Rodnan Skin Score

75 (56.4%)

24 (18.9%)

58 (43.6%)

67 (50.4%)

7 (5.3%)

55 (41.4%)

71 (53.4%)

0 (0%)

32 (24.1%)

1 (0.8%)

1 (0.8%)

13 (9.8%)

10.9 ± 8.7

74 (68.5%)

33 (31.4%)

64 (59.2%)

53 (49.1%)

4 (3.7%)

48 (44.4%)

68 (62.9%)

10 (9.3%)

29 (26.9%)

8 (7.4%)

6 (5.6%)

15 (13.9%)

13.1 ± 11.3

0.05

0.02

0.04

0.33

0.08

0.63

0.06

<0.001

0.62

0.01

0.01

0.32

0.09

* age at unemployment according to self report in the questionnaire

 

Table 2. HRQoL according to employment status measured using SF- in those less than 65 years of age

 

Patient reported outcomes

Employed

mean±SD

Unemployed

mean±SD or n(%)

p-value

Number of patients

133

108

 

SF 36 Domains     Physical functioning     Role physical     Role emotional     Vitality     Mental Health     Social functioning     Bodily Pain     General Health     Physical component score     Mental component score

67.6±24.4

57.9±42.8

75.3±38.8

49.2±21.6

71.1±17.5

75.5±23.1

68.4±23.7

48.2±22.9

41.9±10.3

46.9±10.6

50.6±25.3

29.0±40.4

53.8±45.2

38.3±23.4

66.6±19.8

61.2±24.4

53.6±23.6

36.2±22.2

33.9±10.3

43.2±11.8

<0.001

<0.001

0.001

0.001

0.06

<0.001

<0.001

0.001

<0.001

0.01

PROMIS 29 Domains     Physical function     Anxiety     Depression     Fatigue     Sleep disturbance       Satisfaction with participation in          social roles     Pain interference     Pain intensity global (NRS 0-10)

45.9 (±8.1)

52.2 (±9.8)

50.3 (±9.5)

54.4 (±10.4)

53.4 (±8.3)

75.5 (±23.2)

68.4 (±23.7)

2.8 ± 2.4

40.8 (±7.5)

53.6 (±9.9)

53.4 (±10.1)

58.6 (±10.2)

55.0 (±8.6)

61.2 (±24.4)

53.6 (±23.6)

4.3 ± 2.6

<0.001

0.27

0.01

0.002

0.13

<0.001

<0.001

<0.001

 


Disclosure: K. Morrisroe, None; M. Huq, None; W. Stevens, None; J. Sahhar, None; S. Proudman, None; M. Nikpour, None.

To cite this abstract in AMA style:

Morrisroe K, Huq M, Stevens W, Sahhar J, Proudman S, Nikpour M. Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/work-productivity-in-systemic-sclerosis-and-association-with-health-related-quality-of-life/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/work-productivity-in-systemic-sclerosis-and-association-with-health-related-quality-of-life/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology